Home > Chemicals & Materials > Advanced Materials > Functional Materials > Microcrystalline Cellulose (MCC) Market
Manufacturers are involved in increasing their product lineup to enhance their revenue generation. For instance, in August 2015, DFE Pharma announced the launch of Pharmacel 112 with low-moisture lactose grade for formulating active pharmaceutical ingredients (APIs). The MCC market participants are also undergoing merger & acquisition to strengthen their regional presence and product penetration.
The prominent players operating in the microcrystalline cellulose market share includes:
Consistent R&D investment in the pharmaceutical industry are providing a positive outlook on the new product development and product portfolio expansion. This is resulting in manufacturing several categories of drugs to ensure substantial gains over the projected timeframe. Furthermore, industry players focusing towards fat-free food products is another influencing factor for volume growth over the study timeframe.